Skip to main content
. Author manuscript; available in PMC: 2020 Nov 12.
Published in final edited form as: J Allergy Clin Immunol. 2018 Dec 7;143(3):1038–1046. doi: 10.1016/j.jaci.2018.10.028

FIG 3.

FIG 3.

Differences in baseline epitope and SCP levels between groups achieving desensitization (DS) or SU 8 weeks after MOIT discontinuation. A, Box plots of the baseline overall (z score) epitope-specific IgE binding by MOIT outcome, with significantly different z scores between the SU and DS groups. NR, Nonresponders. B, Heat map representing baseline epitope-specific IgE binding for each patient for the set of epitopes with significant differences (fold change [FCH] > 1.5 and FDR < 0.05) between DS and SU outcomes at baseline. β-LG, β-Lactoglobulin. C, Bar plots of the least square mean (Ismean) with the 95% CI of log10 SCP levels at baseline by MOIT outcome.